CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA

The objectives of this study are to assess the safety and effectiveness of Capivasertib (hereinafter "the study drug") in a real-world practice setting for patients prescribed with the study drug under the approved local label in South Korea. Primary Objective To assess the safety of the study drug in patients prescribed with the study drug under the approved label(s) in South Korea Secondary Objective To assess effectiveness of the study drug in patients prescribed with the study drug under the approved label(s) in South Korea